Alseres Pharmaceuticals to Host 2008 Second Quarter Confe...(rom any future results performance orach...),Health
Navigation Links
Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call
Date:8/7/2008
rom any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. Alseres is providing the information in this press release as of this date and assumes no obligations to update the information in this press release.
Alseres, Cethrin and Altropane are registered trademarks of Alseres
Pharmaceuticals, Inc.
Contact:
Sharon Correia - 508-497-2360 ext. 224
Alseres Pharmaceuticals, Inc.
Adam Friedman - 212-981-2529 ext. 18
Adam Friedman Associates
adam@adam-friedman.com
'/>"/>
| SOURCE Alseres Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
2. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
3. Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
4. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
5. Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call
6. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
7. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
8. Alseres Pharmaceuticals, Inc. Raises $5 Million
9. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
10. Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
11. Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 3Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Don't I know you? University of Toronto research sheds light on memorial retrieval 2Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 2Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 3
[0] Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards [0] Lilly Announces the First 300-unit Vial of Insulin[0] Nearly 3 Million Doses of H1N1 Vaccine Allocated to Pennsylvania since Start of Vaccination Effort[1] Don't I know you? University of Toronto research sheds light on memorial retrieval[1] Docs Not Giving Clear Advice on Infant Sleep Positions
Other Medicine News:Health News:Ignoring Insomnia Costs America $42 Billion a Year 2Health News:Ignoring Insomnia Costs America $42 Billion a Year 3Health News:Keep Your Pets Safe in a Hurricane 2Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 2Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 3Health News:SunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community Hospitals 4Health News:Legal loophole exposes Canadians to drug advertising banned in US: UBC research 2Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 2Health News:Summertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child Injury 3Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 2Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 3
Ignoring Insomnia Costs America $42 Billion a YearKeep Your Pets Safe in a HurricaneSunGard Availability Services and Phoenix Health Systems Join Forces to Deliver Complete Software Application and Infrastructure Management to Community HospitalsLegal loophole exposes Canadians to drug advertising banned in US: UBC researchSummertime or 'Trauma Season?' - Increase in Outdoor Activities Spurs Higher Risk for Child InjuryTime Magazine Reports on Infinitink Tattoo Ink From Nuvilex
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Nonprofit Goes RVing to Promote Pet and Human Health 48962 1Nonprofit Goes RVing to Promote Pet and Human Health 48962 2Nonprofit Goes RVing to Promote Pet and Human Health 48962 3HPV Vaccine Acceptability Study Announces Results 48959 1HPV Vaccine Acceptability Study Announces Results 48959 2HPV Vaccine Acceptability Study Announces Results 48959 3Heart Association Warns of Surgery Risks in Obese 48956 1Heart Association Warns of Surgery Risks in Obese 48956 2
[0] FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging[0] Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease[0] Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
Other Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |